The Precipio Inc (PRPO) share price is expected to decrease by 100% over the next year. This is based on calculating the average 12-month share price estimate provided by 1 stock analysts who have covered PRPO. Price targets range from $ at the low end to $ at the high end. The current analyst consensus for PRPO is a buy. Please note analyst price targets are not guaranteed and could be missed completely.
About 1 Wall Street analysts have assignedPRPO 1 buy ratings, 0 hold ratings, and 0 sell ratings. This means that analysts expect Precipio Inc to buy. Keep in mind that these ratings are typically refreshed every quarter, underscoring the importance of conducting your own research on PRPO. Don't forget to include both technical and fundamental analysis, as well as staying informed on news that could influence these ratings, in your due diligence.
These are the latest 20 analyst ratings of PRPO.
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
---|---|---|---|---|
Maxim Group | Buy | Initiates | Nov 25, 2020 | |
Maxim Group | Buy | Initiates | Nov 22, 2019 |
When did it IPO
N/A
Staff Count
51
Country
United States
Sector/Industry
Healthcare/Diagnostics & Research
CEO
Mr. Ilan Danieli
Market Cap
$9.2M
In 2023, PRPO generated $15.2M in revenue, which was a increase of 61.46% from the previous year. This can be seen as a signal that PRPO's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
No news data available.